A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment


The burden of cancer is rising globally and is estimated to have reached 18.1 million new cases and 9.6 million cancer deaths in 2018. Despite the rising cancer incidence, improvements in early detection and therapeutic treatment have improved cancer survival. As a consequence, the number of cancer survivors is increasing globally, creating the need to improve not only treatment but also wellness and follow‐up care. Cancer treatment often involves combined modalities such as surgery, chemotherapy, and radiotherapy. In the past decades, more effective and targeted therapeutic modalities and less destructive cancer treatments have been developed such as immunotherapy and drug‐targeted therapy. Even so, cancer and its treatment have important physical and psychosocial sequelae. ONCORELIEF is a 36-month action that will leverage the above 6 drivers in order to skillfully and methodologically overcome technical challenges, by introducing new approaches that will allow the utilization of big datasets in order to develop a user-centered AI System to facilitate the integration of QoL assessment instruments through the use of PROMs and PREMs in order to improve post-treatment health status, increase the wellbeing, and follow‐up care of cancer patients. This will be achieved through an intuitive smart digital assistant (Guardian Angel), able to provide personalized support in post-treatment activities and tasks, suggest actions regarding the patients' overall health-status, improved wellbeing and active health-care and ultimately maintain him/her engaged on a wellness journey that will safeguard his/her health over the foreseeable prolonged post-cancer treatment period. To achieve this, ONCORELIEF builds on the combined knowhow of its interdisciplinary industry-driven consortium that brings together state-of-the-art technological skills, design thinking methodology and occupational psychology/health sciences.

Project details

Unibo Team Leader: Antonio Francesco Maturo

Unibo involved Department/s:
Dipartimento di Sociologia e Diritto dell'Economia

Exus Software Ltd(United Kingdom)

Other Participants:
Fraunhofer Ipa (Germany)
Care Across Ltd (United Kingdom)
MAGGIOLI S.p.A. (Italy)
Mcs Datalabs (Germany)
Fciencias Id - Associação Para A Investigação E Desenvolvimento De Ciencias (Portugal)
Innosystems Symvouleutikes Ypiresies Kai Efarmoges Pliroforikis Ypsilis Technologias Monoprosopi Idiotiki Kefalaiouchiki Etaireia (Greece)
ALMA MATER STUDIORUM - Università di Bologna (Italy)
Time.Lex (Belgium)
Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz (Germany)
Irccs Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - Irst S.R.L. (Italy)
Suite5 Data Intelligence Solutions Limited (Cyprus)
Centre For Research And Technology Hellas (Greece)

Total Eu Contribution: Euro (EUR) 4.872.250,00
Project Duration in months: 36
Start Date: 01/01/2020
End Date: 31/12/2022

Cordis webpage
Project website

Good health and well-being This project contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.

UE flag This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 875392